|
46
|
209
|
6t6qAAA |
Crystal structure of toxoplasma gondii morn1 (extended conformation). |
|
58
|
205
|
6t69A |
Crystal structure of toxoplasma gondii morn1(v shape) |
|
35
|
156
|
6u9kA |
Mll1 set n3861i/q3867l bound to inhibitor 18 (tc-5153) |
|
39
|
155
|
6u9nA |
Mll1 set n3861i/q3867l bound to inhibitor 14 (tc-5139) |
|
39
|
155
|
6u9mA |
Mll1 set n3861i/q3867l bound to inhibitor 16 (tc-5109) |
|
41
|
156
|
6u9rA |
Mll1 set n3861i/q3867l bound to inhibitor 12 (tc-5140) |
|
99
|
326
|
6in3A |
Crystal structure of dot1l in complex with 18-crown-6 |
|
7
|
70
|
1g6zA |
Solution structure of the clr4 chromo domain |
|
1
|
27
|
1e0nA |
Yjq8ww domain from saccharomyces cerevisae |
|
10
|
61
|
4pziA |
Zinc finger region of mll2 in complex with cpg dna |
|
5
|
51
|
4nw3A |
Crystal structure of mll cxxc domain in complex with a cpg dna |
|
152
|
429
|
6monA |
Crystal structure of human smyd2 in complex with nle-peptide inhibitor |
|
48
|
160
|
3f9xA |
Structural insights into lysine multiple methylation by set domain methyltransferases, set8-y334f / h4-lys20me2 / adohcy |
|
8
|
57
|
2kkfA |
Solution structure of mll cxxc domain in complex with palindromic cpg dna |
|
35
|
163
|
3q0bX |
Crystal structure of suvh5 sra- fully methylated cg dna complex in space group p42212 |
|
37
|
163
|
3q0fA |
Crystal structure of suvh5 sra- methylated chh dna complex |
|
32
|
162
|
3q0cA |
Crystal structure of suvh5 sra-fully methylated cg dna complex in space group p6122 |
|
34
|
163
|
3q0dA |
Crystal structure of suvh5 sra- hemi methylated cg dna complex |
|
135
|
526
|
4qenA |
Crystal structure of kryptonite in complex with mchh dna and sah |
|
119
|
515
|
6a5nA |
Crystal structure of arabidopsis thaliana suvh6 in complex with methylated dna |
|
20
|
84
|
6mlcA |
Phd6 domain of mll3 in complex with histone h4 |
|
73
|
328
|
6nn6K |
Structure of dot1l-h2bk120ub nucleosome complex |
|
69
|
329
|
6nj9K |
Active state dot1l bound to the h2b-ubiquitinated nucleosome, 2-to-1 complex |
|
88
|
327
|
6nogK |
Poised-state dot1l bound to the h2b-ubiquitinated nucleosome |
|
148
|
423
|
5yjoA |
Crystal structure of smyd3 in complex with covalent inhibitor 4 |
|
67
|
328
|
6nqaK |
Active state dot1l bound to the h2b-ubiquitinated nucleosome, 1-to-1 complex |
|
51
|
185
|
6nm4A |
Crystal structure of sam-bound prdm9 in complex with mrk-740 inhibitor |
|
84
|
324
|
6j99K |
Cryo-em structure of human dot1l in complex with an h2b-monoubiquitinated nucleosome |
|
65
|
261
|
6mbpA |
Glp methyltransferase with inhibitor eml741- p3121 crystal form |
|
69
|
261
|
6mboA |
Glp methyltransferase with inhibitor eml741-p212121 crystal form |
|
49
|
246
|
6agoA |
Crystal structure of mrg15-ash1l histone methyltransferase complex |
|
15
|
60
|
6o7gB |
Solution structure of mll4 phd6 domain in complex with histone h4k16ac peptide |
|
34
|
110
|
5eh2E |
Human prdm9 allele-a znf domain with associated recombination hotspot dna sequence iii |
|
18
|
160
|
5hq2M |
Structural model of set8 histone h4 lys20 methyltransferase bound to nucleosome core particle |
|
71
|
328
|
6o96K |
Dot1l bound to the h2bk120 ubiquitinated nucleosome |
|
77
|
328
|
6jmaX |
Cryo-em structure of dot1l bound to h2b ubiquitinated nucleosome |
|
87
|
328
|
6jm9X |
Cryo-em structure of dot1l bound to unmodified nucleosome |
|
33
|
139
|
6bozA |
Structure of human setd8 in complex with covalent inhibitor ms4138 |
|
58
|
255
|
6ineA |
Crystal structure of human ash1l-mrg15 complex |
|
69
|
261
|
3swcA |
Glp (g9a-like protein) set domain in complex with dnmt3ak44me2 peptide |
|
27
|
107
|
3s8sA |
Crystal structure of the rrm domain of human setd1a |
|
148
|
423
|
5xxgA |
Crystal structure of smyd3 in complex with covalent inhibitor 2 |
|
143
|
423
|
5xxdA |
Crystal structure of smyd3 in complex with covalent inhibitor 1 |
|
74
|
272
|
5vseA |
Structure of human g9a set-domain (ehmt2) in complex with inhibitor 17: n~2~-cyclopentyl-6,7-dimethoxy-n~2~-methyl-n~4~-(1-methylpiperidin-4-yl)quinazoline-2,4-diamine |
|
102
|
327
|
5mw4A |
Crystal structure of dot1l in complex with inhibitor cpd7 [n-(3-(((r)-1-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl)(methyl)amino)propyl)-2-(3-(2-chloro-3-(2-methylpyridin-3-yl)benzo[b]thiophen-5-yl)ureido)acetamide] |
|
103
|
328
|
5mvsA |
Crystal structure of dot1l in complex with adenosine and inhibitor cpd1 [n6-(2,6-dichlorophenyl)-n6-(pent-2-yn-1-yl)quinoline-4,6-diamine] |
|
58
|
247
|
5lssA |
Structure of the epigenetic oncogene mmset and inhibition by n-alkyl sinefungin derivatives |
|
62
|
245
|
5lt8A |
Structure of the epigenetic oncogene mmset and inhibition by n-alkyl sinefungin derivatives |
|
61
|
266
|
5lsyA |
Structure of the epigenetic oncogene mmset and inhibition by n-alkyl sinefungin derivatives |
|
61
|
266
|
5lt7A |
Structure of the epigenetic oncogene mmset and inhibition by n-alkyl sinefungin derivatives |
